HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
Background & Aims: Millions of people worldwide are infected chronically with HBV, which results in significant morbidity and mortality. Therapeutic vaccination is a strategy that aims to induce functional cure by restoring cellular immunity to HBV. Previously we have shown the candidate HBV imm...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2023-11-01
|
| Serier: | JHEP Reports |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2589555923002161 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
